This week on the Caixin-Sinica Business Brief: China’s top regulator quashes rumors of a revived Ant Group IPO; the debate over IVF for single women in China heats up; China’s defense minister Wei Fenghe spits some fire at the Shangri-La Dialogue; and new COVID outbreaks threaten openings in Shanghai and Beijing.
In addition, we speak with Caixin Global financial reporter Yukun Zhang about mass COVID testing, one of the main weapons in China’s anti-COVID arsenal.
